These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 32108423)

  • 1. Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: Results of the multicenter U.S. IDE trial.
    Gillespie MJ; Javois AJ; Moore P; Forbes T; Paolillo JA;
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1296-1304. PubMed ID: 32108423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect.
    Sommer RJ; Love BA; Paolillo JA; Gray RG; Goldstein BH; Morgan GJ; Gillespie MJ;
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1285-1295. PubMed ID: 31943749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined prospective United States clinical study data for the GORE(®) HELEX(®) septal occluder device.
    Rhodes JF; Goble J
    Catheter Cardiovasc Interv; 2014 May; 83(6):944-52. PubMed ID: 23674380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical experience with the GORE
    de Hemptinne Q; Horlick EM; Osten MD; Millán X; Tadros VX; Pighi M; Gonzalez Barlatey F; Alnasser SM; Miró J; Asgar AW; Ibrahim R
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):495-503. PubMed ID: 28128523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-catheter atrial septal defect closure with the new GORE® Cardioform ASD occluder: First European experience.
    Santoro G; Castaldi B; Cuman M; Di Candia A; Pizzuto A; Sirico D; Cantinotti M; Garibaldi S; Pak V; Di Salvo G
    Int J Cardiol; 2021 Mar; 327():68-73. PubMed ID: 33220363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel delivery technique for atrial septal defect closure in young children utilizing the GORE
    Anderson JH; Fraint H; Moore P; Cabalka AK; Taggart NW
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1232-1238. PubMed ID: 27896910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect.
    Javois AJ; Rome JJ; Jones TK; Zahn EM; Fleishman CE; Pignatelli RH; Latson LA;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):905-12. PubMed ID: 25147036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Here today, gone tomorrow: Outcomes of residual leak following secundum atrial septal defect closure with the GORE CARDIOFORM Septal Occluder.
    Gordon BM; Abudayyeh I; Goble J; Collado NA; Paolillo J
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):932-936. PubMed ID: 31876383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gore Cardioform atrial septal occluder: deployment procedure and techniques for closing challenging secundum atrial septal defects.
    Aggarwal V; Mohan AK; Bass J; Steinberger J; Said SM; Qureshi AM
    Cardiol Young; 2021 Dec; 31(12):1885-1892. PubMed ID: 34620264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mullins-Sheath Facilitated Delivery of Gore Cardioform ASD Occluder Devices for Closure of Large or Challenging Secundum Atrial Septal Defects.
    Eilers LF; Gowda ST; Gowda S; Lahiri S; Aggarwal V; Stapleton GE; Gillespie MJ; Qureshi AM
    J Invasive Cardiol; 2021 Jun; 33(6):E425-E430. PubMed ID: 33893794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.
    Shrivastava S; Shrivastava S; Allu SVV; Schmidt P
    Cureus; 2023 Jun; 15(6):e40132. PubMed ID: 37425612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experiences with the GORE(®) Septal Occluder in children and adults with atrial septal defects.
    Nyboe C; Hjortdal VE; Nielsen-Kudsk JE
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):929-34. PubMed ID: 23404677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.
    Grohmann J; Höhn R; Fleck T; Schmoor C; Stiller B
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):E51-7. PubMed ID: 24664494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
    El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.
    Jones TK; Latson LA; Zahn E; Fleishman CE; Jacobson J; Vincent R; Kanter K;
    J Am Coll Cardiol; 2007 Jun; 49(22):2215-21. PubMed ID: 17543643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.
    Grohmann J; Wildberg C; Zartner P; Abu-Tair T; Tarusinov G; Kitzmüller E; Schmoor C; Stiller B; Kampmann C
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):E226-E232. PubMed ID: 27900839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and safety of a new generation of gore septal occluder device in children.
    Lombardi M; Tagliente MR; Pirolo T; Massari E; Milella L; Vairo U
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e249-e251. PubMed ID: 24721761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
    Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
    J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series.
    Kramer P; Opgen-Rhein B; Berger F; Nordmeyer J
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):359-363. PubMed ID: 37313625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study.
    Hardt SE; Eicken A; Berger F; Schubert S; Carminati M; Butera G; Grohmann J; Höhn R; Nielsen-Kudsk JE; Hildick-Smith D; Settergren M; Thomson JD; Geis N; Søndergaard L
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):824-829. PubMed ID: 28296023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.